Molecular Profiles of Pyramidal Neurons in the Superior Temporal Cortex in Schizophrenia

REFERENCES

• Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P., Kavvoura, F. K., Khoury, M. J., et al. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet, 40, 827–834.
   PubMed Web of Science ®Google Scholar
• Ananth, H., Popescu, I., Critchley, H. D., Good, C. D., Frackowiak, R. S., & Dolan, R. J. (2002). Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry, 159, 1497–1505.
   PubMed Web of Science ®Google Scholar
• Arnsten, A. F., Paspalas, C. D., Gamo, N. J., Yang, Y., & Wang, M. (2010). Dynamic Network Connectivity: A new form of neuroplasticity. Trends Cogn Sci, 14, 365–375.
   PubMed Web of Science ®Google Scholar
• Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., et al. (2000). Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci, 20, 2427–2438.
   PubMed Web of Science ®Google Scholar
• Asher, R. A., Morgenstern, D. A., Shearer, M. C., Adcock, K. H., Pesheva, P., & Fawcett, J. W. (2002). Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci, 22, 2225–2236.
   PubMed Web of Science ®Google Scholar
• Barch, D. M., Sheline, Y. I., Csernansky, J. G., & Snyder, A. Z. (2003). Working memory and prefrontal cortex dysfunction: Specificity to schizophrenia compared with major depression. Biol Psychiatry, 53, 376–384.
   PubMed Web of Science ®Google Scholar
• Baskerville, S., & Bartel, D. P. (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA, 11, 241–247.
   PubMed Web of Science ®Google Scholar
• Beck, H. N., Drahushuk, K., Jacoby, D. B., Higgins, D., & Lein, P. J. (2001). Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons. BMC Neurosci, 2, 12.
   PubMed Web of Science ®Google Scholar
• Benes, F. M. (2006). Strategies for improving sensitivity of gene expression profiling: Regulation of apoptosis in the limbic lobe of schizophrenics and bipolars. Prog Brain Res, 158, 153–172.
   PubMed Web of Science ®Google Scholar
• Benes, F. M. (2011). Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropharmacology, 60, 1232–1242.
   PubMed Web of Science ®Google Scholar
• Benes, F. M., Lim, B., Matzilevich, D., Subburaju, S., & Walsh, J. P. (2008). Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci U S A, 105, 20935–20940.
   PubMed Web of Science ®Google Scholar
• Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007). Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci U S A, 104, 10164–10169.
   PubMed Web of Science ®Google Scholar
• Benes, F. M., Matzilevich, D., Burke, R. E., & Walsh, J. (2006). The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry, 11, 241–251.
   PubMed Web of Science ®Google Scholar
• Bergmann, A. (2002). Survival signaling goes BAD. Dev Cell, 3, 607–608.
   PubMed Web of Science ®Google Scholar
• Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet, 17, 1156–1168.
   PubMed Web of Science ®Google Scholar
• Bitanihirwe, B. K., Lim, M. P., Kelley, J. F., Kaneko, T., & Woo, T.-U. W. (2009). Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry, 9, 71.
   PubMed Web of Science ®Google Scholar
• Bowie, C. R., & Harvey, P. D. (2005). Cognition in schizophrenia: Impairments, determinants, and functional importance. Psychiatr Clin North Am, 28, 613–633, 626.
   PubMed Web of Science ®Google Scholar
• Braitenberg, V., & Schuz, A. (1998). Cortex: Statistics and geometry of neuronal connectivity. Berlin: Springer.
   Google Scholar
• Buzsaki, G., & Draguhn, A. (2004). Neuronal oscillations in cortical networks. Science, 304, 1926–1929.
   PubMed Web of Science ®Google Scholar
• Cajigas, I. J., Tushev, G., Will, T. J., tom Dieck, S., Fuerst, N., & Schuman, E. M. (2012). The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron, 74, 453–466.
   PubMed Web of Science ®Google Scholar
• Caretti, E., Devarajan, K., Coudry, R., Ross, E., Clapper, M. L., Cooper, H. S., et al. (2008). Comparison of RNA amplification methods and chip platforms for microarray analysis of samples processed by laser capture microdissection. J Cell Biochem, 103, 556–563.
   PubMed Web of Science ®Google Scholar
• Cascella, N. G., Fieldstone, S. C., Rao, V. A., Pearlson, G. D., Sawa, A., & Schretlen, D. J. (2010). Gray-matter abnormalities in deficit schizophrenia. Schizophr Res, 120, 63–70.
   PubMed Web of Science ®Google Scholar
• Cho, R. Y., Konecky, R. O., & Carter, C. S. (2006). Impairments in frontal cortical {gamma} synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A, 103, 19878–19883.
   PubMed Web of Science ®Google Scholar
• Chou, J., Harvey, B. K., Chang, C. F., Shen, H., Morales, M., & Wang, Y. (2006). Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci, 240, 21–29.
   PubMed Web of Science ®Google Scholar
• Costa, E., Davis, J., Grayson, D. R., Guidotti, A., Pappas, G. D., & Pesold, C. (2001). Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis, 8, 723–742.
   PubMed Web of Science ®Google Scholar
• Derynck, R., & Miyazono, K. o. (2008). The TGF-[beta] family. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
   Google Scholar
• Dhandapani, K. M., & Brann, D. W. (2003). Transforming growth factor-beta: A neuroprotective factor in cerebral ischemia. Cell Biochem Biophys, 39, 13–22.
   PubMed Web of Science ®Google Scholar
• Esquenazi, S., Monnerie, H., Kaplan, P., & Le Roux, P. (2002). BMP-7 and excess glutamate: Opposing effects on dendrite growth from cerebral cortical neurons in vitro. Exp Neurol, 176, 41–54.
   PubMed Web of Science ®Google Scholar
• Frischknecht, R., & Seidenbecher, C. I. (2008). The crosstalk of hyaluronan-based extracellular matrix and synapses. Neuron Glia Biol, 4, 249–257.
   PubMedGoogle Scholar
• Gabriel, C., Ali, C., Lesne, S., Fernandez-Monreal, M., Docagne, F., Plawinski, L., et al. (2003). Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J, 17, 277–279.
   PubMedGoogle Scholar
• Garey, L. J., Ong, W. Y., Patel, T. S., Kanani, M., Davis, A., Mortimer, A. M., et al. (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry, 65, 446–453.
   PubMed Web of Science ®Google Scholar
• Geschwind, D. H., Ou, J., Easterday, M. C., Dougherty, J. D., Jackson, R. L., Chen, Z., et al. (2001). A genetic analysis of neural progenitor differentiation. Neuron, 29, 325–339.
   PubMed Web of Science ®Google Scholar
• Giamanco, K. A., & Matthews, R. T. (2012). Deconstructing the perineuronal net: Cellular contributions and molecular composition of the neuronal extracellular matrix. Neuroscience, 218, 367–384.
   PubMed Web of Science ®Google Scholar
• Giancotti, F. G., & Ruoslahti, E. (1999). Integrin signaling. Science, 285, 1028–1032.
   PubMed Web of Science ®Google Scholar
• Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2006). Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res, 81, 47–63.
   PubMed Web of Science ®Google Scholar
• Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry, 57, 65–73.
   PubMed Web of Science ®Google Scholar
• Guo, X., Rueger, D., & Higgins, D. (1998). Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons. Neurosci Lett, 245, 131–134.
   PubMed Web of Science ®Google Scholar
• Gur, R. E., Cowell, P. E., Latshaw, A., Turetsky, B. I., Grossman, R. I., Arnold, S. E., et al. (2000). Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry, 57, 761–768.
   PubMed Web of Science ®Google Scholar
• Gur, R. E., Turetsky, B. I., Bilker, W. B., & Gur, R. C. (1999). Reduced gray matter volume in schizophrenia. Arch Gen Psychiatry, 56, 905–911.
   PubMed Web of Science ®Google Scholar
• Hanover, J. L., Huang, Z. J., Tonegawa, S., & Stryker, M. P. (1999). Brain-derived neurotrophic factor overexpression induces precocious critical period in mouse visual cortex. J Neurosci, 19, RC40.
   PubMed Web of Science ®Google Scholar
• Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., et al. (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci, 23, 6315–6326.
   PubMed Web of Science ®Google Scholar
• Homayoun, H., & Moghaddam, B. (2007). NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci, 27, 11496–11500.
   PubMed Web of Science ®Google Scholar
• Horbinski, C., Stachowiak, E. K., Chandrasekaran, V., Miuzukoshi, E., Higgins, D., & Stachowiak, M. K. (2002). Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. J Neurochem, 80, 54–63.
   PubMed Web of Science ®Google Scholar
• Horii-Hayashi, N., Okuda, H., Tatsumi, K., Ishizaka, S., Yoshikawa, M., & Wanaka, A. (2008). Localization of chondroitin sulfate proteoglycan versican in adult brain with special reference to large projection neurons. Cell Tissue Res, 334, 163–177.
   PubMed Web of Science ®Google Scholar
• Hyytiainen, M., Penttinen, C., & Keski-Oja, J. (2004). Latent TGF-beta binding proteins: Extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci, 41, 233–264.
   PubMed Web of Science ®Google Scholar
• Ikeda, M., Naitoh, M., Kubota, H., Ishiko, T., Yoshikawa, K., Yamawaki, S., et al. (2009). Elastic fiber assembly is disrupted by excessive accumulation of chondroitin sulfate in the human dermal fibrotic disease, keloid. Biochem Biophys Res Commun, 390, 1221–1228.
   PubMed Web of Science ®Google Scholar
• Iwamoto, K., & Kato, T. (2006). Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist, 12, 349–361.
   PubMed Web of Science ®Google Scholar
• Jia, P., Wang, L., Meltzer, H. Y., & Zhao, Z. (2010). Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data. Schizophr Res, 122, 38–42.
   PubMed Web of Science ®Google Scholar
• Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res, 28, 27–30.
   PubMed Web of Science ®Google Scholar
• Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res, 38 (Database issue), D355–D360.
   PubMed Web of Science ®Google Scholar
• Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., et al. (2006). From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res, 34 (Database issue), D354–D357.
   PubMed Web of Science ®Google Scholar
• Kim, E. S., Kim, R. S., Ren, R. F., Hawver, D. B., & Flanders, K. C. (1998). Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25–35 in cultured neuronal cells. Brain Res Mol Brain Res, 62, 122–130.
   PubMedGoogle Scholar
• Kim, J., Krichevsky, A., Grad, Y., Hayes, G. D., Kosik, K. S., Church, G. M., et al. (2004). Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci U S A, 101, 360–365.
   PubMed Web of Science ®Google Scholar
• Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006). A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci, 26, 1604–1615.
   PubMed Web of Science ®Google Scholar
• Klempt, N. D., Sirimanne, E., Gunn, A. J., Klempt, M., Singh, K., Williams, C., et al. (1992). Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res, 13, 93–101.
   PubMedGoogle Scholar
• Kwon, J. S., O’Donnell, B. F., Wallenstein, G. V., Greene, R. W., Hirayasu, Y., Nestor, P. G., et al. (1999). Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry, 56, 1001–1005.
   PubMed Web of Science ®Google Scholar
• Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401–1414.
   PubMed Web of Science ®Google Scholar
• Le Roux, P., Behar, S., Higgins, D., & Charette, M. (1999). OP-1 enhances dendritic growth from cerebral cortical neurons in vitro. Exp Neurol, 160, 151–163.
   PubMed Web of Science ®Google Scholar
• Lee-Hoeflich, S. T., Causing, C. G., Podkowa, M., Zhao, X., Wrana, J. L., & Attisano, L. (2004). Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J, 23, 4792–4801.
   PubMedGoogle Scholar
• Lewis, D. A., & Gonzalez-Burgos, G. (2008). Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology, 33, 141–165.
   PubMed Web of Science ®Google Scholar
• Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci, 6, 312–324.
   PubMed Web of Science ®Google Scholar
• Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402–408.
   PubMed Web of Science ®Google Scholar
• Luzzi, V., Holtschlag, V., & Watson, M. A. (2001). Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol, 158, 2005–2010.
   PubMed Web of Science ®Google Scholar
• Mahadevappa, M., & Warrington, J. A. (1999). A high-density probe array sample preparation method using 10- to 100-fold fewer cells. Nat Biotechnol, 17, 1134–1136.
   PubMed Web of Science ®Google Scholar
• Massague, J., & Gomis, R. R. (2006). The logic of TGFbeta signaling. FEBS Lett, 580, 2811–2820.
   PubMed Web of Science ®Google Scholar
• Mauney, S. A., Athanas, K. M., Pantazopoulos, H., Shaskan, N., Passeri, E., Berretta, S., et al. (2013). Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol Psychiatry, 74, 427–435.
   PubMed Web of Science ®Google Scholar
• McCarley, R. W., Wible, C. G., Frumin, M., Hirayasu, Y., Levitt, J. J., Fischer, I. A., et al. (1999). MRI anatomy of schizophrenia. Biol Psychiatry, 45, 1099–1119.
   PubMed Web of Science ®Google Scholar
• Melchior, F., & Hengst, L. (2002). SUMO-1 and p53. Cell Cycle, 1, 245–249.
   PubMed Web of Science ®Google Scholar
• Mellios, N., Galdzicka, M., Ginns, E., Baker, S. P., Rogaev, E., Xu, J., et al. (2012). Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull, 38, 433–443.
   PubMed Web of Science ®Google Scholar
• Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011). Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry, 70, 663–671.
   PubMed Web of Science ®Google Scholar
• Mitelman, S. A., Shihabuddin, L., Brickman, A. M., Hazlett, E. A., & Buchsbaum, M. S. (2003). MRI assessment of gray and white matter distribution in Brodmann’s areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry, 160, 2154–2168.
   PubMed Web of Science ®Google Scholar
• Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., & Brzustowicz, L. M. (2011). Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry, 69, 188–193.
   PubMed Web of Science ®Google Scholar
• Morey, J. S., Ryan, J. C., & Van Dolah, F. M. (2006). Microarray validation: Factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online, 8, 175–193.
   PubMed Web of Science ®Google Scholar
• Morgenstern, D. A., Asher, R. A., & Fawcett, J. W. (2002). Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res, 137, 313–332.
   PubMed Web of Science ®Google Scholar
• Moustakas, A., & Heldin, C. H. (2008). Dynamic control of TGF-beta signaling and its links to the cytoskeleton. FEBS Lett, 582, 2051–2065.
   PubMed Web of Science ®Google Scholar
• Ohta, Y., Nakagawa, K., Imai, Y., Katagiri, T., Koike, T., & Takaoka, K. (2008). Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway. J Bone Miner Metab, 26, 478–484.
   PubMed Web of Science ®Google Scholar
• Olney, J. W., & Farber, N. B. (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry, 52, 998–1007.
   PubMed Web of Science ®Google Scholar
• Pantazopoulos, H., Murray, E. A., & Berretta, S. (2008). Total number, distribution, and phenotype of cells expressing chondroitin sulfate proteoglycans in the normal human amygdala. Brain Res, 1207, 84–95.
   PubMed Web of Science ®Google Scholar
• Pantazopoulos, H., Woo, T.-U. W., Lim, M. P., Lange, N., & Berretta, S. (2010). Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch Gen Psychiatry, 67, 155–166.
   PubMed Web of Science ®Google Scholar
• Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., et al. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol, 8, R27.
   PubMed Web of Science ®Google Scholar
• Petegnief, V., Friguls, B., Sanfeliu, C., Sunol, C., & Planas, A. M. (2003). Transforming growth factor-alpha attenuates N-methyl-d-aspartic acid toxicity in cortical cultures by preventing protein synthesis inhibition through an Erk1/2-dependent mechanism. J Biol Chem, 278, 29552–29559.
   PubMed Web of Science ®Google Scholar
• Pfaffl, M. W., Horgan, G. W., & Dempfle, L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 30, e36.
   PubMed Web of Science ®Google Scholar
• Pietersen, C. Y., Lim, M. P., Macey, L., Woo, T.-U. W., & Sonntag, K. C. (2011). Neuronal type-specific gene expression profiling and laser-capture microdissection. Methods Mol Biol, 755, 327–343.
   PubMedGoogle Scholar
• Pietersen, C. Y., Lim, M. P., & Woo, T.-U. W. (2009). Obtaining high quality RNA from single cell populations in human postmortem brain tissue. J Vis Exp,(30).
   Google Scholar
• Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E. (2008). The p53 family and programmed cell death. Oncogene, 27, 6507–6521.
   PubMed Web of Science ®Google Scholar
• Podkowa, M., Zhao, X., Chow, C. W., Coffey, E. T., Davis, R. J., & Attisano, L. (2010). Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation. Mol Cell Biol, 30, 2241–2250.
   PubMed Web of Science ®Google Scholar
• Prehn, J. H., Bindokas, V. P., Marcuccilli, C. J., Krajewski, S., Reed, J. C., & Miller, R. J. (1994). Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci U S A, 91, 12599–12603.
   PubMed Web of Science ®Google Scholar
• Radonic, A., Thulke, S., Mackay, I. M., Landt, O., Siegert, W., & Nitsche, A. (2004). Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun, 313, 856–862.
   PubMed Web of Science ®Google Scholar
• Rauch, U. (2004). Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci, 61, 2031–2045.
   PubMed Web of Science ®Google Scholar
• Ross, S., & Hill, C. S. (2008). How the Smads regulate transcription. Int J Biochem Cell Biol, 40, 383–408.
   PubMed Web of Science ®Google Scholar
• Santarelli, D. M., Beveridge, N. J., Tooney, P. A., & Cairns, M. J. (2011). Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry, 69, 180–187.
   PubMed Web of Science ®Google Scholar
• Selemon, L. D., & Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry, 45, 17–25.
   PubMed Web of Science ®Google Scholar
• Shi, Y., & Ethell, I. M. (2006). Integrins control dendritic spine plasticity in hippocampal neurons through NMDA receptor and Ca2+/calmodulin-dependent protein kinase II-mediated actin reorganization. J Neurosci, 26, 1813–1822.
   PubMed Web of Science ®Google Scholar
• Shi, Y., & Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113, 685–700.
   PubMed Web of Science ®Google Scholar
• Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., et al. (2009). Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson’s disease pathology. Brain, 132 (Pt 7), 1795–1809.
   PubMedGoogle Scholar
• Smith, G. M., & Strunz, C. (2005). Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia, 52, 209–218.
   PubMed Web of Science ®Google Scholar
• Spencer, K. M., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., et al. (2004). Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A, 101, 17288–17293.
   PubMed Web of Science ®Google Scholar
• Suga, M., Yamasue, H., Abe, O., Yamasaki, S., Yamada, H., Inoue, H., et al. (2010). Reduced gray matter volume of Brodmann’s Area 45 is associated with severe psychotic symptoms in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci, 260, 465–473.
   PubMed Web of Science ®Google Scholar
• Super, H., & Uylings, H. B. (2001). The early differentiation of the neocortex: A hypothesis on neocortical evolution. Cerebral Cortex, 11, 1101–1109.
   PubMed Web of Science ®Google Scholar
• Svitkina, T., Lin, W. H., Webb, D. J., Yasuda, R., Wayman, G. A., Van Aelst, L., et al. (2010). Regulation of the postsynaptic cytoskeleton: Roles in development, plasticity, and disorders. J Neurosci, 30, 14937–14942.
   Google Scholar
• Sweet, R. A., Bergen, S. E., Sun, Z., Sampson, A. R., Pierri, J. N., & Lewis, D. A. (2004). Pyramidal cell size reduction in schizophrenia: Evidence for involvement of auditory feedforward circuits. Biol Psychiatry, 55, 1128–1137.
   PubMed Web of Science ®Google Scholar
• Sweet, R. A., Henteleff, R. A., Zhang, W., Sampson, A. R., & Lewis, D. A. (2009). Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology, 34, 374–389.
   PubMed Web of Science ®Google Scholar
• Sweet, R. A., Pierri, J. N., Auh, S., Sampson, A. R., & Lewis, D. A. (2003). Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology, 28, 599–609.
   PubMed Web of Science ®Google Scholar
• Uhlhaas, P. J., & Singer, W. (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci, 11, 100–113.
   PubMed Web of Science ®Google Scholar
• Vermeulen, J., De Preter, K., Lefever, S., Nuytens, J., De Vloed, F., Derveaux, S., et al. (2011). Measurable impact of RNA quality on gene expression results from quantitative PCR. Nucleic Acids Res, 39, e63.
   PubMed Web of Science ®Google Scholar
• Vivien, D., & Ali, C. (2006). Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev, 17, 121–128.
   PubMed Web of Science ®Google Scholar
• Wilke, M., Kaufmann, C., Grabner, A., Putz, B., Wetter, T. C., & Auer, D. P. (2001). Gray matter-changes and correlates of disease severity in schizophrenia: A statistical parametric mapping study. Neuroimage, 13, 814–824.
   PubMed Web of Science ®Google Scholar
• Wozniak, M. A., Modzelewska, K., Kwong, L., & Keely, P. J. (2004). Focal adhesion regulation of cell behavior. Biochim Biophys Acta, 1692, 103–119.
   PubMed Web of Science ®Google Scholar
• Yamasue, H., Iwanami, A., Hirayasu, Y., Yamada, H., Abe, O., Kuroki, N., et al. (2004). Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: An MRI parcellation study. Psychiatry Res, 131, 195–207.
   PubMed Web of Science ®Google Scholar
• Zaharieva, I., Georgieva, L., Nikolov, I., Kirov, G., Owen, M. J., O’Donovan, M. C., et al. (2008). Association study in the 5q31–32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry, 8, 11.
   PubMed Web of Science ®Google Scholar
• Zhou, Y. X., Zhao, M., Li, D., Shimazu, K., Sakata, K., Deng, C. X., et al. (2003). Cerebellar deficits and hyperactivity in mice lacking Smad4. J Biol Chem, 278, 42313–42320.
   PubMed Web of Science ®Google Scholar